Expert Highlights Latest Advances, Next Steps in HER2+ Breast Cancer
Published: Thursday, May 09, 2019
Joanne Mortimer, MD
Data from the phase III KATHERINE trial in early HER2-positive breast cancer and smaller studies in the metastatic setting are shaping modern treatment models and testifying to the prospect of improved prognoses, explained Joanne Mortimer, MD.
... to read the full story